Related Experiment Video
Updated: Jul 26, 2025

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
The Impact of Proactive Gastrostomy Tube Placement on Treatment-related Outcomes in Young Children With High-grade
Chelsea Kotch1,2, Caitlin W Elgarten1,2, Jessica McWhorter1
1Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia.
Insights
Proactive gastrostomy tube (GT) placement may modestly reduce weight loss in young children with central nervous system (CNS) tumors during chemotherapy. However, benefits for hospitalization and nutrition support were not significant compared to nasogastric tubes (NGT).
Area of Science:
- Pediatric Oncology
- Clinical Nutrition
- Medical Devices
Background:
- Young children with high-grade central nervous system (CNS) tumors face malnutrition risks during intensive chemotherapy.
- Existing guidelines for enteral tube placement in this population are lacking.
- Previous research on proactive gastrostomy tube (GT) placement focused on limited outcomes like weight.
Purpose of the Study:
- To evaluate the comprehensive impact of proactive gastrostomy tube (GT) placement on treatment outcomes in young children with high-grade CNS tumors.
- To compare outcomes between proactive GT, rescue GT, and nasogastric tube (NGT) cohorts.
Main Methods:
- Single-center, retrospective study of children under 60 months with high-grade CNS tumors.
- Patients treated between 2015 and 2022 per CCG99703 or ACNS0334 protocols.
- Analysis of outcomes including weight loss, antibiotic use, parenteral nutrition, and hospitalization duration.
Main Results:
- Proactive GT placement was associated with less clinically significant weight loss during induction (22%) compared to NGT (47%), though not statistically significant (P=0.274).
- No significant differences were observed between cohorts in antibiotic or parenteral nutrition utilization, weight loss at therapy completion, or hospitalization duration.
- A total of 26 patients were included: 9 (35%) proactive GT, 8 (30%) rescue GT, and 9 (35%) NGT.
Conclusions:
- Proactive gastrostomy tube (GT) placement shows modest effectiveness in preventing significant weight loss during the induction phase of chemotherapy for young children with CNS tumors.
- There was no clear benefit of proactive GT over nasogastric tube (NGT) regarding hospitalization duration, antibiotic requirements, or parenteral nutrition needs.
- An individualized approach to gastrostomy tube (GT) placement is recommended for pediatric patients with CNS malignancies receiving intensive chemotherapy.
Abstract:
Young children undergoing treatment with intensive chemotherapy for high-grade central nervous system (CNS) tumors are at risk for malnutrition, yet no guidelines exist for the placement of enteral tubes. Prior studies evaluated the impact of proactive gastrostomy tube (GT) placement with a narrow scope of outcomes, such as weight. To examine the impact of proactive GT on comprehensive treatment outcomes, we performed a single-center, retrospective study of children younger than 60 months of age with high-grade CNS tumors treated per CCG99703 or ACNS0334 between 2015 and 2022. Of 26 patients included, 9 (35%) underwent proactive GT, 8 (30%) had rescue GT, and 9 (35%) had a nasogastric tube (NGT). Clinically significant weight loss occurred in 47% of patients with NGT during induction compared with 22% with proactive GT ( P = 0.274); however, between cohorts, there was no significant difference in antibiotic or parenteral nutrition utilization, weight loss at therapy completion, and duration of hospitalization. Therefore, proactive GT placement was modestly effective at preventing significant weight loss during induction, however, there was no clear benefit for hospitalization duration, antibiotic, or parental nutrition requirements compared with NGT. We recommend an individualized approach to GT placement for young children with CNS malignancies undergoing intensive chemotherapy.
Related Concept Videos
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Enteral Nutrition I: Orogastric and Nasogastric Feeding
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
